Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry-Reference-Cited by-同舟云学术

Everolimus-eluting bioresorbable vascular scaffolds versus second generation drug-eluting stents for percutaneous treatment of chronic total coronary occlusions: Technical and procedural outcomes from the GHOST-CTO registry

Published:2016-01-12 Issue:6 Volume:88 Page:E155-E163
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Cathet. Cardiovasc. Intervent.

Author:

La Manna Alessio¹,Chisari Alberto¹,Giacchi Giuseppe¹,Capodanno Davide¹,Longo Giovanni¹,Di Silvestro Michele¹,Capranzano Piera¹,Tamburino Corrado¹²

Affiliation:

1. Cardiovascular Department; Ferrarotto Hospital, University of Catania; Catania Italy

2. Excellence through Newest Advances (ETNA) Foundation; Catania Italy

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ccd.26397/fullpdf

Reference22 articles.

1. Percutaneous recanalization of chronic total occlusions: Wherein lies the body of proof?;Tamburino;Am Heart J,2013

2. Effects of percutaneous revascularization of chronic total occlusions on clinical outcomes: A meta-analysis comparing successful versus failed percutaneous intervention for chronic total occlusion;Khan;Catheter Cardiovasc Interv,2013

3. Long-term follow-up of elective chronic total coronary occlusion angioplasty: Analysis from the U.K. Central Cardiac Audit Database;George;J Am Coll Cardiol,2014

4. Outcomes with first- versus second-generation drug-eluting stents in coronary chronic total occlusions (CTOs): A systematic review and meta-analysis;Lanka;J Invasive Cardiol,2014

5. Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial;Gert van Houwelingen;Catheter Cardiovasc Interv,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Selection Preference on Longer-Term Outcomes between Bioresorbable Vascular Scaffold versus Everolimus-Eluting Stent for True Lumen Tracking-Recanalized Chronic Total Occlusion;International Heart Journal;2023-03-31

2. Optical coherence tomography evaluation of the absorb bioresorbable scaffold performance for overlap versus non-overlap segments in patients with coronary chronic total occlusion: insight from the GHOST-CTO registry;The International Journal of Cardiovascular Imaging;2019-06-07

3. Hybrid Coronary Percutaneous Treatment with Metallic Stents and Everolimus-Eluting Bioresorbable Vascular Scaffolds: 2-Years Results from the GABI-R Registry;Journal of Clinical Medicine;2019-05-30

4. Bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: a meta-analysis;BMC Cardiovascular Disorders;2019-03-15

5. Bioresorbable vascular scaffolds for complex chronic total occlusions;Cardiovascular Revascularization Medicine;2019-03